Is the new indulekha hair serum really effective
Searching the Web
Indulekha hair serum effectiveness review 2025 2026
Searching the Web
Indulekha Bringha scalp serum honest review ingredients Redensyl clinical trial
Here's a balanced breakdown of the Indulekha Bringha Hair Growth Serum (their newer scalp serum product):
What It Claims
Indulekha's Bringha Hair Growth Serum makes several specific claims:
- Grows 11,000 new hair strands in 90 days (based on an internal clinical study)
- 2x better than 3% Redensyl (a well-known hair growth active)
- Powered by Ayurvedic actives: Bhringraj, Amla, and Brahmi
The Reality Check
1. Ingredients - some are legit
- Bhringraj (Eclipta alba) has genuine traditional support for hair growth, and some small studies suggest it may stimulate hair follicles
- Amla (Indian gooseberry) is a well-established antioxidant that can improve scalp health
- Brahmi has some evidence for reducing hair fall
- Redensyl comparison: Redensyl is a clinically tested ingredient (dihydroquercetin-glucoside + EGCG2) with independent peer-reviewed backing. The claim of being "2x better than Redensyl" comes from Indulekha's own internal study - not independent peer-reviewed research
2. The Clinical Claims Have Caveats
- The "11,000 new strands in 90 days" and "2x Redensyl" claims are from brand-funded studies, not published, independent clinical trials
- One reviewer specifically noted (as recently as 2026) that Indulekha does not fully disclose the ingredient list for this serum - a concern for transparency
- Self-funded cosmetic studies routinely show favorable results; independent replication is what matters
3. User Experiences Are Mixed
- Some users do report reduced hair fall and baby hair growth after 4-8 weeks of consistent use
- Others see minimal change, which is typical for most hair serums
- The product is described as lightweight and non-sticky, which helps with compliance (you're more likely to use it daily)
Verdict
| Factor | Assessment |
|---|---|
| Ingredient quality | Decent - Ayurvedic herbs have traditional + some scientific backing |
| Clinical evidence | Weak - brand-funded only, not independent |
| User reviews | Mixed but leaning positive for hair fall reduction |
| Transparency | Below average - incomplete ingredient disclosure |
| Value for money | Moderate - priced mid-range for Indian market |
Bottom line: It may help with mild hair fall and scalp health if used consistently for 90+ days - the Ayurvedic ingredients aren't bogus. But the bold "11,000 strands" and "2x Redensyl" claims should be taken with skepticism since they come from the brand's own trials. For significant hair thinning or androgenic alopecia, consult a dermatologist - prescription options like minoxidil have far stronger independent evidence.
How does this compare to other Ayurvedic hair serums or Minoxidil?
Searching the Web
Ayurvedic hair serum vs minoxidil hair loss effectiveness comparison 2025
Searching PubMed
minoxidil topical hair loss efficacy clinical trial
Searching the Web
Ayurvedic hair serum India comparison WOW Biotique Mamaearth Indulekha review
Here is a thorough comparison across three categories:
1. Indulekha vs. Other Ayurvedic Hair Serums
| Product | Key Actives | Evidence Type | Transparency | Price Range |
|---|---|---|---|---|
| Indulekha Bringha Serum | Bhringraj, Amla, Brahmi, Redensyl | Brand-funded internal study | Incomplete ingredient list | Mid (₹400-600) |
| WOW Onion Hair Serum | Onion extract, Biotin, Argan oil | Mostly user testimonials | Reasonably disclosed | Low-Mid (₹300-500) |
| Mamaearth Onion Hair Serum | Onion extract, Plant Keratin | User testimonials | Well disclosed | Low (₹250-400) |
| Biotique Bio Bhringraj | Bhringraj, Amla, mineral oil | Traditional/anecdotal | Partially disclosed | Low (₹150-250) |
| Kesh King | Bhringraj, Neem, 21 herbs | Advertised claim-based | Moderate | Low-Mid |
Key differences:
- Indulekha does stand out by at least attempting a clinical comparison (vs. Redensyl), which most Indian Ayurvedic brands don't bother to do
- The Redensyl inclusion is a genuine differentiator - it is a patented active targeting hair follicle stem cells with some independent studies behind it
- Most competitors in this price range rely purely on marketing language with no trial data at all
- Ingredient transparency remains a weakness for Indulekha specifically in 2026, per independent reviewers
2. Ayurvedic Serums vs. Minoxidil - The Real Gap
This is where the evidence diverges sharply.
Minoxidil's track record:
- FDA-approved (since 1988 for topical use)
- Dozens of independent, peer-reviewed RCTs and meta-analyses
- A 2025 meta-analysis (PMID: 39425514) confirmed both oral and topical minoxidil are effective for androgenetic alopecia, with oral showing slightly superior results
- Mechanism is understood: prolongs anagen (growth) phase, widens hair follicles, increases local blood flow
- Works in ~60-70% of users when used consistently for 4-6 months
Ayurvedic serums (including Indulekha):
- No independent peer-reviewed RCTs exist for Indulekha specifically
- Bhringraj has small studies supporting follicle stimulation, but none at the scale of minoxidil trials
- A 2025 Springer review on hair loss treatments acknowledges interest in herbal alternatives to minoxidil but notes the evidence gap is still significant
3. When to Use Which
| Situation | Best Option |
|---|---|
| Mild, diffuse hair fall (stress, nutrition) | Ayurvedic serum may be sufficient |
| Early androgenetic alopecia (genetic thinning) | Minoxidil is first-line; can combine with scalp serum |
| Moderate-to-severe hair loss / receding hairline | Minoxidil + dermatologist consult (consider finasteride) |
| Scalp health maintenance / no clinical hair loss | Ayurvedic serums are fine |
| Want to avoid side effects of minoxidil | Redensyl-based serums (like Indulekha) are a reasonable gentler alternative |
Bottom Line
Indulekha is among the better formulated Ayurvedic serums in India, primarily because it includes Redensyl alongside the herbal actives. But the entire Ayurvedic serum category still sits well below minoxidil in terms of clinical proof. If you have noticeable thinning or genetic hair loss, minoxidil (2% or 5% topical) remains far more evidence-backed. Ayurvedic serums work best as a maintenance or complementary product, not a standalone treatment for significant hair loss.
Give me a breakdown of the recent indulekha hair serum clinical study
Searching the Web
Indulekha Bringha hair serum clinical study details methodology results 2024 2025
Searching the Web
Indulekha hair serum "clinical trial" "11000" OR "11,000" study participants methodology
Reading Web Page
Indulekha clinical study methodology participants results hair growth
Good - I now have enough detail to give you a thorough breakdown. Note that there are actually two separate studies - one on the hair oil (published in IJORD) and two on the newer serum (2024 + 2025). Here's the full picture:
The Indulekha Bringha Hair Growth Serum - Clinical Study Breakdown
Study Overview
There are actually two trials for the serum, both announced May 2026:
| Study 1 | Study 2 | |
|---|---|---|
| Year conducted | 2024 | 2025 |
| Publication status | Already published | Submitted to Int. Journal of Research in Dermatology |
| Conducted by | Registered Clinical Research Organisations (CROs) | Same |
| Supervised by | Dermatologists + Ayurvedic practitioners | Same |
| Participants | Men & women, age 20-45 | Same profile |
| Hair loss stage | Early to moderate hair thinning | Same |
What Was Measured
The trials evaluated these parameters:
- New hair strand growth (count)
- Hair shedding / hair fall reduction
- Follicle strength
- Anagen-to-Telogen (A:T) ratio (the key biological hair cycle metric)
- Scalp barrier function
- Hair density
- Hair thickness and volume (self-reported)
Key Results Claimed
Objective (measured) outcomes:
- 11,000+ new hair strands grown in 90 days
- 74% improvement in the Anagen-to-Telogen ratio - meaning more follicles were shifted into the active growth phase
- 2x more hair growth than 3% Redensyl formulations (comparative arm)
Self-reported (subjective) outcomes:
- 100% of participants observed thicker-looking hair
- 97% reported a noticeable reduction in hair fall
- 97% experienced improvement in hair density
- 97% agreed the serum increases thickness and improves hair volume
Red Flags and Limitations - What They Don't Tell You
1. Sample size not disclosed
The press releases do not state how many participants were enrolled. This is a significant omission - a 97-100% positive outcome in a very small group (e.g. 30 people) is far less meaningful than in a 300-person trial.
2. No placebo/control group mentioned for the serum study
Unlike the hair oil trial (which compared to coconut oil), the serum studies' press releases do not clarify whether there was a placebo arm. Without one, it's impossible to separate the serum's effect from natural hair cycle variation.
3. "2x better than Redensyl" needs context
The comparator is specifically "serums containing 3% Redensyl" - not minoxidil, not finasteride. Redensyl is a weaker benchmark. This framing is marketing-friendly but scientifically narrow.
4. All results are brand-funded and released via press release
The announcement came through PTI (a wire service) and appeared in Hindustan Times and The Wire - these are paid/auto-published press releases, not independent editorial coverage. The 2025 data has not yet been peer-reviewed.
5. 100% positive subjective outcomes is a warning sign
In legitimate clinical trials, 100% agreement on any subjective outcome is almost never seen. It suggests either a very small sample, an optimistic framing of the questions, or a highly selected participant group.
The One Legitimate Published Study (Hair Oil, Not Serum)
The published IJORD study was on the Bringha Hair Oil (not the serum), but is the most scientifically credible Indulekha study available:
- Randomized, single-blinded, placebo-controlled design
- Compared to coconut oil (control)
- 4-month treatment period with monthly follow-up visits
- Results: ~20% increase in follicular density, >40% reduction in hair fall from roots
- This one has actual methodology you can scrutinize
Bottom Line Assessment
| Criterion | Score |
|---|---|
| Study design quality | Unknown (details withheld) |
| Independence | Low - brand-funded, CRO-run |
| Peer review | Partial (2024 published; 2025 pending) |
| Transparency | Poor - no sample size, no protocol details public |
| Claimed results | Impressive but unverifiable without full paper |
The studies are more credible than a typical "90% of 10 women agreed" cosmetic claim - CRO involvement and dermatologist supervision are real steps up. But without the full published paper for the serum (sample size, randomization, blinding, control arm), you cannot truly evaluate the claims. Wait for the 2025 paper to appear in IJORD before treating those numbers as settled science.
This is a shared conversation. Sign in to Orris to start your own chat.